HF
ITCI

HRT Financial’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

HRT Financial’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-26,030
Closed -$2.17M – 3600
2024
Q4 		$2.17M Sell
26,030
-140,719
-84% -$11.6M 0.01% 708
2024
Q3 		$12.2M Sell
166,749
-73,447
-31% -$5.52M 0.06% 203
2024
Q2 		$16.5M Buy
+240,196
New +$16.7M 0.09% 164
2024
Q1 		– Sell
-13,767
Closed -$985K – 3254
2023
Q4 		$985K Buy
+13,767
New +$792K 0.01% 991
2022
Q4 		– Sell
-10,279
Closed -$478K – 3310
2022
Q3 		$478K Buy
+10,279
New +$537K 0.01% 1651
2021
Q4 		– Sell
-39,041
Closed -$1.46M – 4253
2021
Q3 		$1.46M Buy
+39,041
New +$1.36M 0.01% 964
2021
Q1 		– Sell
-10,545
Closed -$335K – 3248
2020
Q4 		$335K Buy
+10,545
New +$277K 0.01% 1223

Other funds holding ITCI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return